Cargando…
Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patients
Coronavirus disease 2019 (COVID-19) infection caused by the severe acute respiratory syndrome coronavirus 2 virus, its symptoms, treatment, and post-COVID-19 effects have been a major focus of research since 2020. In addition to respiratory symptoms, different clinical variants of the virus have bee...
Autores principales: | Ahsan, Khansa, Anwar, Munir Ahmad, Munawar, Nayla |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10107217/ https://www.ncbi.nlm.nih.gov/pubmed/37077515 http://dx.doi.org/10.3748/wjg.v29.i11.1708 |
Ejemplares similares
-
Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics?
por: Munawar, Nayla, et al.
Publicado: (2021) -
Modulation of Gut Microbial Diversity through Non-Pharmaceutical Approaches to Treat Schizophrenia
por: Munawar, Nayla, et al.
Publicado: (2022) -
Role of gut microbiota in the pathogenesis and therapeutics of minimal hepatic encephalopathy via the gut-liver-brain axis
por: Luo, Ming, et al.
Publicado: (2023) -
Therapeutic possibilities of gut microbiota modulation in acute decompensation of liver cirrhosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2023) -
The gut microbiome in human immunodeficiency virus infection
por: Zilberman-Schapira, Gili, et al.
Publicado: (2016)